Abstract
Bruton's tyrosine kinase (BTK) inhibition is one of the treatment standards for patients with relapsed/refractory Waldenstrom's macroglobulinemia (WM)......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
